Skip to Main Content

Paper Details

Targeting the Coronavirus Nucleocapsid Protein through GSK-3 Inhibition.
medRxiv
7
2021
COVID-, COVID-19, Coronavirus, Coronavirus Nucleocapsid Protein, GSK-3, GSK-3 consensus sequences, GSK3A, GSK3B, MERS-CoV, Middle East respiratory syndrome, N, SARS, SARS-CoV, SARS-CoV-, SARS-CoV-2, SARS-CoV-2 N protein, SARS-CoV-2 infected lung epithelial cells, SARS-CoV-2 nucleocapsid protein, betacoronavirus epidemics, coronavirus, coronaviruses, glycogen synthase kinase 3, glycogen synthase kinase-3, human, human lung epithelial cells, lithium, nucleocapsid protein, patients, severe acute respiratory syndrome

Datasets

Release 1.2